# In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-10 19:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Endpoints News | Manufacturing problems cited in FDA rejection of ITM's radiopharma drug | 2026-08-10 15:13 | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxOa1dXNEhUdFhzUnZTSFJBRC1yTFdKejVKNzlNdVVtN1JpVnd2RTZDOUI5amNWSktCZjlqT1pvcHVZU1dHa00xUDNlQXk1Q25KZVBHcll5cWREbVh2aVVRVDdmUUxuOUN4XzR2S2ZralhNNE5RRUVPdzZvSm1YYTVKd1dVOExZTnRnNGlnQW9n?oc=5) |
| AuntMinnie | ITM receives Complete Response Letter for ITM-11 | 2026-08-10 15:13 | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxOS3FINkpoaFRqdkZfd1VPN0Mxd25UX19lS1BHUWVSUWFDUjAyQnM3SmppbWZyT0t4cWVYQ2NPQzhMOUVUT3NLNHJ2b3dqYTk2OVlHWmYwdVByUm1hZjNwUW8teUZ3RzZIODdNWW1kOGpxeFZ0Xy1DXzhQcERwU2Z5U2dDSDE1dXFLY2EzdFA2TEhPWFVhTndvR1M3dUJNNENVejFqNmhjRVpWVlY3Rlh1cDVSekMxemlpZ1pHdTFkUWNlNlpvLWw4el9xNmN4NEV5WVNF?oc=5) |
| cancernetwork.com | 177Lu-Edoterotide Handed CRL by FDA For GEP-NETs Treatment | 2026-08-10 15:13 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxOSnl5X1MzNTRlTDFwcFE0N2EzOTBITHUwNE1wZ1VTeTVXbU9vSkFsWC1jS2I2UmVVdXNkRktnTnRuTnFuQ0JqQWozRG9UWFhhOXYyUE1qN0V1SVdBZER5WGRjcDJyX0RKQS13dnZTc1IxbkhOaV9lVU02YVBUZ1BraXNEeUxNZ2xRcjNhSGdxckQ0RHRQMzdMYw?oc=5) |
| WBOC TV | ITM Receives Complete Response Letter for ¹⁷⁷Lu-edotreotide (ITM-11) | 2026-08-10 15:13 | [Source Link](https://news.google.com/rss/articles/CBMi-AFBVV95cUxPNjduby1GN1JzT0JxejItd0hQVExjQlk3UzhGd3lQbWpzMXB1R28yOWJCeXpkdDBoa2VCaXdlNW9LXzFyLVZaWjIwTU9JQVlfYU5QbTVWVnhDNm1iYkJkWVFoeTRRbklFb0VmUWNPYjBhbDFpZVJkN0VGVXcyVmRMUW9pNzNqTTZBdE0wWDZ0Z2lfV3NJbXdWODBoakdpaWNRQS02emRBNUF1Yy1NVnNPSWRmY1RKVjhJbk5OTjlJVkttY1JMVExoVzlHRVpuTEhLZUQ0U0l3R1VReTk5eGtVM2JweDdWVlg5U2p5aUViTlU2S2N3Ymp1NA?oc=5) |
| TradingView | ITM Says FDA Issues Complete Response Letter For 177Lu-Edotreotide (ITM-11) NDA | 2026-08-10 15:13 | [Source Link](https://news.google.com/rss/articles/CBMi4AFBVV95cUxPS21ZTTJVUlFfZjJkYlZ2YWo1M2MwOWZrMlpBeDJ4SkI0NEc0WEUzVVN2M1BuQ000MHlWZEdLbjRId1VpMVZ4c3NqX3NlZkNudXBYcFVLaVhhQ2k2emVmbTkyVm5HWFBvOTVGRURCanA3ZUxFRnJGUVJsQzhRYzBPc1JEdTdlX3E1cjJtaVRkTXFESHhyX2ZJSktKRVNuWkVBc3ltQS1tNWZKZEtfNUpuZGpzQXVqYlRtdjJHSW5OMWFxcmdMVk1LWTlsMlBRVlZfSW1FN3J3NDZIa01lSERDZA?oc=5) |
| Fierce Pharma | ITM cancer drug spurned by FDA over manufacturing qualms | 2026-08-10 15:13 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxNUEl2Ty1iT3UtdXE3bjRSeHZuSkNud3JzLXdNZzg2MGNieVRfSHdBVlk3SFNvLVpXQ3N4TG52WXdaanVoNi1nTEljUk4xVXBRcktqeFlBWjdlYTJXNGp6WjR1SWNSN0ZVQThFUF8zTGg1ZzNXM2drU0VjOHluMG0zVXlqcUx1Q2xSd2xoWkRHV201djMxbVVsWm0wYmZaNHp2SFc5NVdJZzVsTzlrVldF?oc=5) |
| STAT | In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment | 2026-08-10 15:13 | [Source Link](https://news.google.com/rss/articles/CBMidEFVX3lxTE54eE9UYlZWRVdON1hjQjFIT25BSFAtWExZTUNuRmhiS0RjNEd2SVN6dGI2SE5COXcwQzRMMHROeVR1bmZLamd0QnVqQzZaUGprMUxWN1haUmV5NjhDNVF2OVpKYWppSF8zakdnWDN6ZmV4cmhO?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-10/in-surprise-decision-fda-rejects-radiopharma-therapy-expected-to-rival-novartis*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*